Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
Clinical trial NCT03439709 · UNKNOWN
Trial details
- NCT number
- NCT03439709
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2022-06-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.